Clinical trials: Depression With Prominent Agitation
Depression With Prominent Agitation
The Quietude Study: Quetiapine Use for Agitated Depression
Most individuals with major depressive disorder manifest clinically significant agitation. Concurrent agitation in a depressed individual is associated with an intensification of mood symptoms, decreased probability of recovery…
- Trial name
- NCT01363310
- Testing
- Quetiapine XR, Escitalopram
- Where
- 11 sites in Canada
- Volunteers
- 250 people
- Sponsor
- Physicians Research And Education Network